TMO - Latest News
Thermo Fisher Scientific Inc. (TMO), operates in Healthcare / Medical - Diagnostics & Research, trades on NYSE.
Market capitalization stands near $218.62B. Trailing twelve-month P/E ratio is 31.28. Beta to the broader market is 0.85.
The article list below shows the most recent TMO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent TMO Headlines
Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside
seekingalpha.com - Aug 16, 2026
Thermo Fisher Scientific is rated a Buy, supported by accelerating organic growth and improving Pharma and Biotech end markets. TMO's recent acquisit
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?
fool.com - Aug 13, 2026
Active management and a charitable mission drive Simplify's 42% gain, but iShares offers lower costs and higher dividend income for conservative inves
Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist
businesswire.com - Aug 12, 2026
LUXEMBOURG & NEW YORK & PARIS--(BUSINESS WIRE)--Astorg, a leading pan-European private equity firm, today announced the successful completion of its a
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
businesswire.com - Aug 12, 2026
WALTHAM, Mass. --(BUSINESS WIRE)--Thermo Fisher Scientific Inc.
Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost
reuters.com - Aug 10, 2026
Thermo Fisher Scientific is eyeing a 15%-20% increase in its customer base in India over the next five years, betting on the growing biopharma resear
How News Affects TMO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TMO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked TMO news questions
- What is the latest TMO news headline?
- The most recent TMO headline (Aug 16, 2026) is "Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the TMO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What TMO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual TMO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.